(12) Patent Application Publication (10) Pub. No.: US 2009/0285919 A1 Alberte Et Al

Total Page:16

File Type:pdf, Size:1020Kb

(12) Patent Application Publication (10) Pub. No.: US 2009/0285919 A1 Alberte Et Al US 20090285919A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0285919 A1 Alberte et al. (43) Pub. Date: Nov. 19, 2009 (54) RCE BRAN EXTRACTS FOR filed on Sep. 30, 2008, provisional application No. NFLAMMATION AND METHODS OF USE 61/147,305, filed on Jan. 26, 2009. THEREOF Publication Classification (76) Inventors: Randall S. Alberte, Estero, FL (51) Int. Cl. (US); William P. Roschek, JR., A 6LX 36/899 (2006.01) Naples, FL (US) A2.3L I/28 (2006.01) Correspondence Address: A6IP 29/00 (2006.01) FOLEY HOAG, LLP A6IP 25/00 (2006.01) PATENT GROUP, WORLD TRADE CENTER A6IP35/00 (2006.01) WEST (52) U.S. Cl. ......................................... 424/750; 426/655 155 SEAPORT BLVD BOSTON, MA 02110 (US) (57) ABSTRACT The present invention relates in part to stabilized rice bran (21) Appl. No.: 12/467,835 extracts enriched in compounds that have inhibitory activity against certain anti-inflammatory therapeutic endpoints, such (22) Filed: May 18, 2009 as the COX-1, COX-2 and 5-LOX enzymes. Another aspect of the invention relates to pharmaceutical compositions com Related U.S. Application Data prising the extracts and to methods of treating inflammatory (60) Provisional application No. 61/054,151, filed on May diseases comprising administering the aforementioned 18, 2008, provisional application No. 61/101.475, eXtractS. Patent Application Publication Nov. 19, 2009 Sheet 1 of 6 US 2009/0285919 A1 Figure l Arachidonic Acid NSAIDs inhibition Prostaglandins PRO-NFLAMMATORY Arthritis (OA & RA) Patent Application Publication Nov. 19, 2009 Sheet 2 of 6 US 2009/0285919 A1 S.---------------Sssssssssss &s asy xxx s -Yvxxxxxxxxxxxxxxxxxxxx xxxx-xxxxxxxxxx:x O SSSSS i Patent Application Publication Nov. 19, 2009 Sheet 3 of 6 US 2009/0285919 A1 s k's se Sces SS Sasa SS W s sex&s SNYSS SY wass saxsex's ax xxx Patent Application Publication Nov. 19, 2009 Sheet 4 of 6 US 2009/0285919 A1 SSSSSSSSS as: SS Sw & ses YYYYYYYYYYYYYYYYY-axYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY.saw AYYYYYYYYYYYYSR S. S 'ty?an81-J S. Patent Application Publication Nov. 19, 2009 Sheet 5 of 6 US 2009/0285919 A1 09.tz00709800809Z00Z09.T. Patent Application Publication Nov. 19, 2009 Sheet 6 of 6 US 2009/0285919 A1 09~ US 2009/02859 19 A1 Nov. 19, 2009 RICE BRAN EXTRACTS FOR vents the propagation of free radical reactions. Because of its NFLAMMATION AND METHODS OF USE radical scavenging antioxidant properties, vitamin E inhibits THEREOF lipid peroxidation in vitro and in vivo. Tocotrienols also have antitumor action against breast cancers and possible benefi RELATED APPLICATIONS cial effects on cardiovascular health, and they decrease serum 0001. This application claims the benefit of priority to total cholesterol and LDL cholesterol levels (Ardiansyah, H. U.S. Provisional Application Nos. 61/054,151, filed on May Shirakawa, T. Koseki, K. Ohinata, K. Hashizume and M. 18, 2008, 61/101,475, filed on Sep. 30, 2008, and 61/147,305, Komai, 2006. Rice bran fractions improve blood pressure, filed on Jan. 26, 2009, each of which is herein incorporated by lipid profile, and glucose metabolism in Stroke-prone spon reference in its entirety. taneously hypertensive rats, J. Agric. Food Chem. 54: 1914 1920; T. Akihisa, K. Yasukawa, M. Yamaura, M. Ukiya, Y. BACKGROUND OF THE INVENTION Kimura, N. Shimizu and K. Arai, 2000. Triterpene alcohol and sterol ferulates from rice bran and their anti-inflamma 0002 Rice (Oryza sativa) bran, comprising 10% of the tory effects, J. Agric. Food Chem. 48:2313-2319; A. total rice grain, is a by-product of rice milling industry with Idouraine, M.J. Khan and C. W. Weber, 1996. In vitrobinding world production of about 50-60 million metric tons per year. capacity of wheat bran, rice bran, and oat fiberfor Ca,Mg, Cu, Rice bran is an excellent source of lipids, especially unsatur ated fatty acids. Rice bran oil contains an array of bio-active and Zn alone and in different combinations, J. Agric. Food phytochemicals such as ory Zanols, phytostetols, tocotrienols, Chem. 44:2067-2072: E. H. Jung, S. Ran Kim, I. K. Hwang flavonoids, vitamins, squalene, polycosanols, phytic acid, and T. Youl Ha, 2007. Hypoglycemic effects of a phenolic ferulic acid, inositol hexaphophate. Additional constituents acid fraction of rice bran and ferulic acid in C57BL/KSJ-db/ of the bran include protein (11-15%), carbohydrates (34 db mice, J. Agric. Food Chem. 55.9800-9804; R. Renuka 62%), ash (7-10%), vitamins, minerals and crude fibers Devi and C. Arumughan, 2007. Antiradical efficacy of phy (7-11%) (M. C. Kik, 1956. Nutritive value of rice, nutrients in tochemical extracts from defatted rice bran, Food Chem. Toxi rice bran and rice polish and improvement of protein quality col. 45:2014-2021). with amino acids, J. Agric. Food Chem. 4: 170-172; C. A. 0005 Various techniques used for extraction, isolation Rohrer and T. J. Siebenmorgen, 2004. Nutraceutical concen and purification of antioxidants from rice bran have been trations within the bran of various Rrice kernel thickness described in literature. (M. H. Chen and C.J. Bergman, 2005. fractions, Biosys. Eng. 88:453-460). A rapid procedure for analysing rice bran tocopherol, tocot 0003 Rice bran oil contains 95.6% saponifiable lipids, rienol and gamma-oryZanol contents, Journal of Food Com including glycolipid and phospholipids; and 4.2% unsaponi position and Analysis. 18:319-331 )A rapid procedure for fiable lipids, including tocopherols, tocotrienols, Y-ory Zanol, analyzing rice brantocopherol, tocotrienol and ory Zanol con sterols and carotenoids. The Saponifiable lipids are mainly tents by using hexane, isopropanol and methanol as solvents triglycerides. However, these triglycerides are easily hydro has been developed (S. Lilitchan, C. Tangprawat, K. Aryusuk, lyzed by lipase to form fatty acids. Y-ory Zanol content in the S. Krisnangkura, S. Chokmoh and K. Krisnangkura, 2008. rice bran oil is approximately 0.98%-2.9%. The Y-oryZanol is Partial extraction method for the rapid analysis of total lipids a mixture of 10 ferulate esters of triterpene alcohol that have and gamma-ory Zanol contents in rice bran, Food Chem. been characterized extensively. The Y-oryZanols protect rice 106:752-759). It was found that the tocopherol, tocotrienol bran oil from oxidation, inhibit peroxidation of lipids medi and oryzanol in fresh rice bran were 98.3 mg/g, 223.6 mg/g ated by iron or UV irradiation, and has been shown to lower and 3.4-3.9 mg/g fresh bran weight. Renuka Devi et al. (R. blood cholesterol and used to treat nerve imbalance (C. Agui Renuka Devi and C. Arumughan, 2007. Antiradical efficacy lar-Garcia, G. Gavino, M. Baragano-Mosqueda, P. Hevia and of phytochemical extracts from defatted rice bran, Food V. C. Gavino, 2007. Correlation of tocopherol, tocotrienol, Chem. Toxicol. 45:2014-2021) provided (R. Renuka Devi and gamma-oryZanol and total polyphenol content in rice bran C. Arumughan, 2007. Phytochemical characterization of with different antioxidant capacity assays, Food Chem. 102: defatted rice bran and optimization of a process for their 1228-1232; Ardiansyah, H. Shirakawa, T. Koseki, K. Ohi extraction and enrichment, Bioresource Technology. nata, K. Hashizume and M. Komai, 2006. Rice bran fractions 98:3037-3043) a phytochemical characterization of defatted improve blood pressure, lipid profile, and glucose metabo rice branand optimization of a process for their extraction and lism in stroke-prone spontaneously hypertensive rats, J. enrichment. The yield of total phenols, oryzanols and ferulic Agric. Food Chem. 54: 1914-1920). The major components of acid with methanol were 0.22, 0.03 and 0.023%, respectively. Y-ory Zanol in rice bran are cycloartenyl ferulate, 24-methyl Microwave assisted solvent extraction is a relatively new ene cycloartanyl ferulate and campestanyl ferulate (S. Lilit extraction method that has be used for oil extractions. More chan, C. Tangprawat, K. Aryusuk, S. Krisnangkura, S. Chok recently, supercritical carbon dioxide (SCCO) extractions moh and K. Krisnangkura, 2008. Partial extraction method have shown that the odor and the flavor of extracted oil are for the rapid analysis of total lipids and gamma-oryZanol superior to that obtained by traditional solvent extraction. (C. contents in rice bran, Food Chem. 106:752-759). Balachandran, P. N. Mayamol, S. Thomas, D. Sukumar, A. 0004 Rice bran oil contains about 0.1-0.14% vitamin E. Sundaresan and C. Arumughan, 2008. An ecofriendly Vitamin E is a generic term for a group of four tocopherols approach to process rice bran for high quality rice bran oil (Cl-, 3-, y- and 6-) and four tocotrienols (Cl-, 3-, y- and Ö-), of using Supercritical carbon dioxide for nutraceutical applica which C-tocopherol has the highest biological activity. All tions, Bioresource Technology. 99:2905-2912) SCCO, components of vitamin E have an amphiphilic structure with extraction can overcome limitations of traditional techniques a hydrophilic (chromanol ring) and a hydrophobic dominant that affect extract quality. As a solvent, CO is non-toxic and (isoprenoid side chain). A number of studies showed that can be easily and completely removed from products; more Vitamin E functions as a chain-breaking antioxidant that pre over, it is non-corrosive and non-flammable. In addition to the US 2009/02859 19 A1 Nov. 19, 2009 well characterized oil and fatty acid components of rice bran, but they still do not synthesize PGD, TxB or PGF (J. M. rice bran is rich in phenolics, alkaloids, gingerols and terpe Bathon, F. H. Chilton, W. C. Hubbard, M. C. Towns, N. J. CS. Solan and D. Proud, 1996. Mechanisms of prostanoid syn 0006. The inflammatory cascades responsible for pain, thesis in human synovial cells: cytokine-peptide synergism, join immobility and swelling in osteoarthritis (OA) and rheu Inflammation. 20:537-554).
Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2013/0315843 A1 HAUGHT Et Al
    US 2013 0315843A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0315843 A1 HAUGHT et al. (43) Pub. Date: Nov. 28, 2013 (54) COMPOSITION FOR REDUCTION OF TRPA1 Related U.S. Application Data AND TRPV1 SENSATIONS (60) Provisional application No. 61/652,035, filed on May (71) Applicant: The Procter & Gamble Company, 25, 2012, provisional application No. 61/682,887, (US) filed on Aug. 14, 2012. Publication Classification (72) Inventors: John Christian HAUGHT, West Chester, OH (US); Koti (51) Int. Cl. SREEKRISHNA, Mason, OH (US); A618/42 (2006.01) Sourav DAS, Kolkata (IN); Steve A618/35 (2006.01) Hamilton HOKE, II, West Chester, OH A61O 11/00 (2006.01) (US); Timothy Woodrow A618/37 (2006.01) COFFINDAFFER, Maineville, OH A61O5/10 (2006.01) (US); Katharine Anne BAKES, A618/30 (2006.01) Cincinnati, OH (US); William Michael (52) U.S. Cl. GLANDORF, Mason, OH (US) CPC. A61K 8/42 (2013.01); A61O 5/10 (2013.01); A61K 8/30 (2013.01); A61O II/00 (2013.01); (73) Assignee: The Procter & Gamble Company, A61K 8/37 (2013.01); A61K 8/35 (2013.01) Cincinnati, OH (US) USPC ...................... 424/48; 435/29: 8/406; 424/53 (57) ABSTRACT (21) Appl. No.: 13/873,749 A personal care composition and method of using a personal care composition having menthol and/or hydrogen peroxide (22) Filed: Apr. 30, 2013 and a TRPA1 and/or TRPV1 receptor antagonists. US 2013/03 15843 A1 Nov. 28, 2013 COMPOSITION FOR REDUCTION OF TRPA1 able as a positive signal of efficacy. Further, Some of these AND TRPV1 SENSATIONS molecules may exhibit the ability to reduce sulfur and amine species present in the body in the form of Michael Acceptors FIELD OF THE INVENTION (Yoshida et al., Tetrahedron Letters, 51:5134-5136 (2010)).
    [Show full text]
  • Capsicum Oleoresin and Homocapsaicin
    Printed on: Wed Jan 06 2021, 02:44:36 AM Official Status: Currently Official on 06-Jan-2021 DocId: 1_GUID-1560FD9B-BE0F-495E-9994-C5718733DB4C_2_en-US (EST) Printed by: Jinjiang Yang Official Date: Official as of 01-May-2019 Document Type: USP @2021 USPC 1 nordihydrocapsaicin, nonivamide, decanylvanillinamide, Capsicum Oleoresin and homocapsaicin. DEFINITION ASSAY Capsicum Oleoresin is an alcoholic extract of the dried ripe · CONTENT OF TOTAL CAPSAICINOIDS fruits of Capsicum. It contains NLT 6.5% of total Mobile phase: A mixture of acetonitrile and diluted capsaicinoids, calculated as the sum of capsaicin, phosphoric acid (1 in 1000) (2:3) dihydrocapsaicin, nordihydrocapsaicin, nonivamide, Standard solution A: 0.2 mg/mL of USP Capsaicin RS in decanylvanillinamide, and homocapsaicin, all calculated on methanol the anhydrous basis. The nonivamide content is NMT 5% of Standard solution B: 0.1 mg/mL of USP the total capsaicinoids, calculated on the anhydrous basis. Dihydrocapsaicin RS in methanol [CAUTIONÐCapsicum Oleoresin is a powerful irritant, and Sample solution: 5 mg/mL of Capsicum Oleoresin in even in minute quantities produces an intense burning methanol. Pass a portion of this solution through a filter of sensation when it comes in contact with the eyes and 0.2-µm pore size, and use the filtrate as the Sample solution. tender parts of the skin. Care should be taken to protect Chromatographic system the eyes and to prevent contact of the skin with (See Chromatography á621ñ, System Suitability.) Capsicum Oleoresin.] Mode: LC IDENTIFICATION
    [Show full text]
  • Retention Indices for Frequently Reported Compounds of Plant Essential Oils
    Retention Indices for Frequently Reported Compounds of Plant Essential Oils V. I. Babushok,a) P. J. Linstrom, and I. G. Zenkevichb) National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA (Received 1 August 2011; accepted 27 September 2011; published online 29 November 2011) Gas chromatographic retention indices were evaluated for 505 frequently reported plant essential oil components using a large retention index database. Retention data are presented for three types of commonly used stationary phases: dimethyl silicone (nonpolar), dimethyl sili- cone with 5% phenyl groups (slightly polar), and polyethylene glycol (polar) stationary phases. The evaluations are based on the treatment of multiple measurements with the number of data records ranging from about 5 to 800 per compound. Data analysis was limited to temperature programmed conditions. The data reported include the average and median values of retention index with standard deviations and confidence intervals. VC 2011 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved. [doi:10.1063/1.3653552] Key words: essential oils; gas chromatography; Kova´ts indices; linear indices; retention indices; identification; flavor; olfaction. CONTENTS 1. Introduction The practical applications of plant essential oils are very 1. Introduction................................ 1 diverse. They are used for the production of food, drugs, per- fumes, aromatherapy, and many other applications.1–4 The 2. Retention Indices ........................... 2 need for identification of essential oil components ranges 3. Retention Data Presentation and Discussion . 2 from product quality control to basic research. The identifi- 4. Summary.................................. 45 cation of unknown compounds remains a complex problem, in spite of great progress made in analytical techniques over 5.
    [Show full text]
  • Electrophysiological and Behavioral Characterization Of
    Deletre et al. Parasites & Vectors (2015) 8:316 DOI 10.1186/s13071-015-0934-y RESEARCH Open Access Electrophysiological and behavioral characterization of bioactive compounds of the Thymus vulgaris, Cymbopogon winterianus, Cuminum cyminum and Cinnamomum zeylanicum essential oils against Anopheles gambiae and prospects for their use as bednet treatments Emilie Deletre1* , Fabrice Chandre2, Livy Williams3, Claire Duménil1, Chantal Menut4 and Thibaud Martin1,5 Abstract Background: Laboratory and field studies showed that repellent, irritant and toxic actions of common public health insecticides reduce human-vector contact and thereby interrupt disease transmission. One of the more effective strategies to reduce disease risk involves the use of long-lasting treated bednets. However, development of insecticide resistance in mosquito populations makes it imperative to find alternatives to these insecticides. Our previous study identified four essential oils as alternatives to pyrethroids: Thymus vulgaris, Cymbopogon winterianus, Cuminum cyminum, Cinnamomum zeylanicum. The objectives of this study were to identify active compounds of these essential oils, to characterize their biological activity, and to examine their potential as a treatment for bednets. Methods: We evaluated the electrophysiological, behavioural (repellency, irritancy) and toxic effects of the major compounds of these oils against Anopheles gambiae strain ‘Kisumu’. Results: Aldehydes elicited the strongest responses and monoterpenes the weakest responses in electroantennogram (EAG) trials. However, EAG responses did not correlate consistently with results of behavioral assays. In behavioral and toxicity studies, several of the single compounds did exhibit repellency, irritancy or toxicity in An. gambiae; however, the activity of essential oils did not always correlate with activity expected from the major components. On the contrary, the biological activity of essential oils appeared complex, suggesting interactions between individual compounds and the insect under study.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0279073 A1 Donsky Et Al
    US 20160279073A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0279073 A1 Donsky et al. (43) Pub. Date: Sep. 29, 2016 (54) TERPENE AND CANNABINOID Publication Classification FORMULATIONS (51) Int. Cl. A63L/01 (2006.01) (71) Applicant: FULL SPECTRUM A63L/05 (2006.01) LABORATORIES, LTD., Dublin 2 A636/85 (2006.01) (IE) A63L/352 (2006.01) A63L/05 (2006.01) (72) Inventors: Marc Donsky, Denver, CO (US); A6II 47/36 (2006.01) Robert Winnicki, Denver, CO (US) A 6LX 9/27 (2006.01) A63L/045 (2006.01) (21) Appl. No.: 15/033,023 (52) U.S. Cl. CPC ............... A6 IK3I/01 (2013.01); A61K 9/127 (22) PCT Fed: Oct. 31, 2014 (2013.01); A61 K3I/015 (2013.01); A61 K 31/045 (2013.01); A61K 31/352 (2013.01); (86) PCT No.: PCT/B2O14/OO3156 A61 K3I/05 (2013.01); A61K 47/36 (2013.01); A61K 36/185 (2013.01) S 371 (c)(1), (2) Date: Apr. 28, 2016 (57) ABSTRACT The present invention provides stable, fast-acting liposome and micelle formulations of terpenes, hemp oil, cannabi Related U.S. Application Data noids, or mixtures of a cannabinoid and terpenes or hemp oil and cannabinoids that are Suitable for pharmaceutical and (60) Provisional application No. 61/898,024, filed on Oct. nutraceutical applications. Also provided are methods for 31, 2013. the manufacture of micelle and liposomal formulations. US 2016/0279.073 A1 Sep. 29, 2016 TERPENE AND CANNABINOID medical conditions, including glaucoma, AIDS wasting, FORMULATIONS neuropathic pain, treatment of spasticity associated with multiple Sclerosis, fibromyalgia and chemotherapy-induced PRIORAPPLICATION INFORMATION nausea.
    [Show full text]
  • FEMA GRAS 29 December 2019 SUPPLEMENTARY INFORMATION 1
    SUPPLEMENTARY INFORMATION 1: Identity for Natural Flavor Complexes as Evaluated by the Expert Panel The Identification Description as Reviewed by the FEMA FEMA No.1 FEMA Primary Name Expert Panel Rebaudioside M ≥80%; Rebaudioside D 5-20%; Total 4895 Rebaudioside M steviol glycosides ≥95%. Glutamic acid 35-40%; Other amino acids 1-2%; Total Corynebacterium glutamicum corn nitrogen 6-7%; Aliphatic primary alcohols, aldehydes, 4907 syrup fermentation product carboxylic acids, acetals and esters containing additional oxygenated functional groups 1-2%; Minerals 9-11% Inosine 5´-monophosphate 20-25%; Amino acids 7-8%; Corynebacterium stationis corn 4908 Minerals 23-25%; water 28-37%; Other nucleotides 1-2%; syrup fermentation product Total nitrogen 5-8% Supraglucosylated steviol glycosides 70-80%; Rebaudioside Glucosylated steviol glycosides, 4909 A 14-20%; Steviol glycosides not further glucosylated, each 70-80% individually, not to exceed 3%; Maltodextrin 3-10% Supraglucosylated steviol glycosides 30-40%; Rebaudioside Glucosylated steviol glycosides, A 5-8%; Not more than 4% stevioside; All other individual 4910 40% steviol glycosides not further glucosylated <3%; Maltodextrin 45-60% Stevioside 70-80%; Rebaudioside A 13-18%; Steviobioside 1- 3%; Rebaudioside C 2-3%; Total glycosides (including 4911 Stevia extract stevioside, 70% Rebaudioside D, Rebaudioside B, Rebaudioside F, Dulcoside A, and Rubusoside) <3% Derived from hibiscus blossom calyces (Hibiscus sabdariffa L.) , Hibiscus blossom extract is measured as water 30-60%; 4912 Hibiscus
    [Show full text]
  • St. John's Wort 2018
    ONLINE SERIES MONOGRAPHS The Scientific Foundation for Herbal Medicinal Products Hyperici herba St. John's Wort 2018 www.escop.com The Scientific Foundation for Herbal Medicinal Products HYPERICI HERBA St. John's Wort 2018 ESCOP Monographs were first published in loose-leaf form progressively from 1996 to 1999 as Fascicules 1-6, each of 10 monographs © ESCOP 1996, 1997, 1999 Second Edition, completely revised and expanded © ESCOP 2003 Second Edition, Supplement 2009 © ESCOP 2009 ONLINE SERIES ISBN 978-1-901964-61-5 Hyperici herba - St. John's Wort © ESCOP 2018 Published by the European Scientific Cooperative on Phytotherapy (ESCOP) Notaries House, Chapel Street, Exeter EX1 1EZ, United Kingdom www.escop.com All rights reserved Except for the purposes of private study, research, criticism or review no part of this text may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, without the written permission of the publisher. Important Note: Medical knowledge is ever-changing. As new research and clinical experience broaden our knowledge, changes in treatment may be required. In their efforts to provide information on the efficacy and safety of herbal drugs and herbal preparations, presented as a substantial overview together with summaries of relevant data, the authors of the material herein have consulted comprehensive sources believed to be reliable. However, in view of the possibility of human error by the authors or publisher of the work herein, or changes in medical knowledge, neither the authors nor the publisher, nor any other party involved in the preparation of this work, warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for results obtained by the use of such information.
    [Show full text]
  • [6]-Gingerol in Db/Db Mice
    International Journal of Medicine and Medical Sciences. Vol. 1(12), pp. 536-544, December, 2009. Available online at http://www.academicjournals.org/ijmms ISSN 2006-9723 ©2009 Academic Journals Full Length Research Paper Anti-hyperglycaemic, lipid lowering and anti-oxidant properties of [6]-gingerol in db/db mice Amar Bahadur Singh1, Akanksha2, Nilendra Singh3, Rakesh Maurya2 and Arvind Kumar Srivastava1* 1Biochemistry Division, Central Drug Research Institute, Lucknow-226001, India. 2Medicinal and Process Chemistry Division, CDRI, Lucknow-226001, India. 3Pharmacology Division CDRI, Lucknow-226001, India. Accepted 3 August, 2009 In the present study, we investigated the blood glucose lowering, lipid lowering and antioxidant effect of [6]- gingerol in type 2 diabetic db/db mice. Treatment of db/db mice with [6]-gingerol (100 mg/kg bw) for 12 days significantly (p<0.05) lowered fasting blood glucose and improved the glucose tolerance in db/db mice. Oral administration of [6]-gingerol also significantly (p < 0.05) decreased plasma triglycerides (TG), total cholesterol (TC), free fatty acid (FFA), low-density lipoprotein cholesterol (LDL-C) and plasma insulin concentration. In addition, [6]-gingerol significantly (p < 0.05) reduces the content of hydrogen peroxide or suppresses the reactive oxygen species (ROS) generation and restores the enzyme activity of catalase (CAT), glutathione peroxidase (GPx) and superoxide dismutase (SOD) in db/db mice. These findings suggest that [6]-gingerol exhibits a significant potential as an anti-hyperglycaemic, lipid lowering and anti- oxidant agent for the treatment of type 2 diabetes. Key words: Antihyperglycaemic, antioxidant, antilipidemic, reactive oxygen species, db/db mice, [6]-gingerol. INTRODUCTION Diabetes mellitus is a chronic metabolic disease which stress, which is believed to be a pathogenetic factor in now afflicts approximately 3% of the world population.
    [Show full text]
  • Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer
    Published OnlineFirst October 11, 2011; DOI: 10.1158/1940-6207.CAPR-11-0224 Cancer Prevention Research Article Research Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer Suzanna M. Zick1, D. Kim Turgeon3, Shaiju K. Vareed6, Mack T. Ruffin1, Amie J. Litzinger1, Benjamin D. Wright1, Sara Alrawi1, Daniel P. Normolle2, Zora Djuric1, and Dean E. Brenner3,4,5 Abstract Inhibitors of COX indicate that upregulation of inflammatory eicosanoids produced by COX, and in particular prostaglandin E2 (PGE2), are early events in the development of colorectal cancer (CRC). Ginger has shown downregulation of COX in vitro and decreased incidence/multiplicity of adenomas in rats. This study was conducted to determine if 2.0 g/d of ginger could decrease the levels of PGE2, 13-hydroxy- octadecadienoic acids, and 5-, 12-, and 15-hydroxyeicosatetraenoic acid (5-, 12-, and 15-HETE), in the colon mucosa of healthy volunteers. To investigate this aim, we randomized 30 subjects to 2.0 g/d ginger or placebo for 28 days. Flexible sigmoidoscopy at baseline and day 28 was used to obtain colon biopsies. A liquid chromatography mass spectrometry method was used to determine eicosanoid levels in the biopsies, and levels were expressed per protein or per free arachidonic acid. There were no significant differences in mean percent change between baseline and day 28 for any of the eicosanoids, when normalized to protein. There was a significant decrease in mean percent change in PGE2 (P ¼ 0.05) and 5-HETE (P ¼ 0.04), and a trend toward significant decreases in 12-HETE (P ¼ 0.09) and 15-HETE (P ¼ 0.06) normalized to free arachidonic acid.
    [Show full text]
  • Cyclic Voltammetric Determination of Capsaicin by Using Electrochemically Deposited Tin and Reduced Graphene Oxide on Screen-Printed Carbon Electrodes
    R ESEARCH ARTICLE doi: 10.2306/scienceasia1513-1874.2020.076 Cyclic voltammetric determination of capsaicin by using electrochemically deposited tin and reduced graphene oxide on screen-printed carbon electrodes Wasukamol Numphud, Orapin Chienthavorn, Wilai Siriwatcharapiboon∗ Department of Chemistry and the Center of Excellence for Innovation in Chemistry, Faculty of Science, Kasetsart University, Bangkok 10903 Thailand ∗Corresponding author, e-mail: [email protected] Received 28 May 2020 Accepted 19 Aug 2020 ABSTRACT: Tin and reduced graphene oxide (Sn/rGO) was prepared by an electrochemical deposition and modified on a screen-printed carbon electrode (SPCE) in order to improve the electrode selectivity and sensitivity for determination of capsaicin in real samples. The modified electrode was characterized for its surface morphology by scanning electron microscopy (SEM). An elemental analysis of prepared catalysts was confirmed by energy dispersive spectroscopy (EDS) and x-ray photoelectron spectroscopy (XPS). The experimental conditions influencing determination of capsaicin were optimized. The experiment was carried out in a sodium acetate buffer solution pH 3.0 at a scan rate of 50 mV/s. The Sn/rGO/SPCE showed a linear working range of 0.2–22 µM of capsaicin concentrations. The limit of detection and limit of quantification were 0.005 µM (S/N=3) and 0.02 µM (S/N=10), respectively. The prepared electrode was successfully applied to determine capsaicin in real chili samples and chili sauces. KEYWORDS: capsaicin detection, modified electrode, electrocatalyst, electrochemical sensor INTRODUCTION chromatography (HPLC) [6], gas chromatography- mass spectrometry (GC-MS) 15 , and liquid Chili is one of the most popular ingredients in food [ ] chromatography-mass spectrometry (LC-MS) 16 , owing to its unique characteristics for desirable [ ] have been reported.
    [Show full text]
  • Utilizing LC/UV and LC/MS for the Characterization, Isolation, And
    Utilizing LC/UV and LC/MS for the Characterization, Isolation, and Quantitation of Capsaicinoids in Chili Peppers and Hot Sauces J Preston, Seyed Sadjadi, Zeshan Aqeel, and Sky Countryman Phenomenex, Inc., 411 Madrid Ave., Torrance, CA 90501 USA PO19040114_W_2 PO14400613_W_2 Abstract Hot and spicy food has dramatically increased in popu- al different chili peppers and commercially available hot larity over the past 10-20 years. Capsaicin is the most sauces. Prep HPLC is then used to isolate individual cap- abundant compound found in chili peppers giving them saicinoids from the pepper extracts. Finally, a triple qua- their fiery flavor. Capsaicin is formed when vanillylamine druple MS system is employed to identify and quantitate is coupled to a 10 carbon fatty acid through an amide link- the observed capsaicinoids. age. However, there are other related compounds often called capsaicinoids. These compounds have the same Capsaicin was found to be the most prevalent capsaicinoid vanillylamine group but differ by the associated fatty acid species in all of the studied matrices. Significant amounts chain and are responsible for the perception of different of Nordihydrocapsaicin were found in a cayenne hot sauce heat profiles for different chili peppers. Some peppers are and in Thai chili pepper extract. Dihydrocapsaicin and Ho- described as having a high initial flash of heat while other modihydrocapsaicin were also identified in many of the in- peppers are described by a long and late burning profile. vestigated chili extracts and hot sauces but at lower levels. The typical concentration of these compounds were found The work presented here, initially uses HPLC with UV to be in the µg/g range but varied widely among the differ- detection to profile capsaicinoids extracted from sever- ent chili peppers and hot sauces.
    [Show full text]
  • New Natural Agonists of the Transient Receptor Potential Ankyrin 1 (TRPA1
    www.nature.com/scientificreports OPEN New natural agonists of the transient receptor potential Ankyrin 1 (TRPA1) channel Coline Legrand, Jenny Meylan Merlini, Carole de Senarclens‑Bezençon & Stéphanie Michlig* The transient receptor potential (TRP) channels family are cationic channels involved in various physiological processes as pain, infammation, metabolism, swallowing function, gut motility, thermoregulation or adipogenesis. In the oral cavity, TRP channels are involved in chemesthesis, the sensory chemical transduction of spicy ingredients. Among them, TRPA1 is activated by natural molecules producing pungent, tingling or irritating sensations during their consumption. TRPA1 can be activated by diferent chemicals found in plants or spices such as the electrophiles isothiocyanates, thiosulfnates or unsaturated aldehydes. TRPA1 has been as well associated to various physiological mechanisms like gut motility, infammation or pain. Cinnamaldehyde, its well known potent agonist from cinnamon, is reported to impact metabolism and exert anti-obesity and anti-hyperglycemic efects. Recently, a structurally similar molecule to cinnamaldehyde, cuminaldehyde was shown to possess anti-obesity and anti-hyperglycemic efect as well. We hypothesized that both cinnamaldehyde and cuminaldehyde might exert this metabolic efects through TRPA1 activation and evaluated the impact of cuminaldehyde on TRPA1. The results presented here show that cuminaldehyde activates TRPA1 as well. Additionally, a new natural agonist of TRPA1, tiglic aldehyde, was identifed
    [Show full text]